ICU Medical Inc. (ICUI)
NASDAQ: ICUIHealth CareMedical/Dental InstrumentsUSD
At close: Oct 20, 4:00 PM ET · Delayed 15 min
After hours: 161.08 0.00%
ICUI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.03B
- P/E (TTM)
- 135.36
- Forward P/E
- 16.70
- EPS (TTM)
- $1.19
- Dividend yield
- None
- 52-week range
- 113.37 – 192.85
- Day range
- 160.57 – 164.00
- Volume / Avg
- 158.68K / 270.95K
- Beta
- —
- Shares outstanding
- 25.01M
- Next earnings
- Nov 5, 2026
52-week range
ICUI stock today
Shares of ICU Medical (ICUI) finished lower on Oct 20 at $161.08, a drop of 0.10% or $0.16 per share, versus the S&P 500's 0.28% gain. At this level, ICUI sits in the middle of its 52-week range of $113.37 to $192.85: 16.5% below the high, set on Aug 7, 2026 and 42.1% above the low. ICUI is up 13.0% year to date, outperforming the S&P 500 (+12.4%). Over the past 12 months, the stock has gained 37.4%.
At 135.4x trailing earnings, ICU Medical trades above the peer-group median of 48.4x. Its forward P/E of 16.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Nov 5; analysts expect EPS of $1.75.
Summary generated from market data by MetaCap's automated system. Methodology
About ICU Medical
Company profileICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Vivek Jain
- Headquarters
- San Clemente, CA
- Employees
- 13,000
- IPO year
- 1992
- Website
- icumed.com
Financial highlights
Full financialsIn fiscal 2025, ICU Medical generated $2.23 billion in revenue, down 6.3% from fiscal 2024, its first annual decline since 2023. Net income was $732,000, for a net margin of 0.0% versus a median of -1.3% in the prior 5 years. Gross margin was 36.8% (up from 34.6%) and operating margin 1.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B |
| Growth | -6.33% | +5.44% | -0.92% | +73.21% | +3.56% |
| Net income | $732.00K | $-117.69M | $-29.66M | $-74.29M | $103.14M |
| EPS (diluted) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 |
Analyst forecast
ForecastConsensus (8 analysts)
none
Avg. price target
$193.38+20.05%
- Strong buy 3
- Buy 4
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $1.75
- Last reported (Q2 2026)
- Aug 6, 2026
- EPS actual vs est.
- $0.76 vs —
ICUI news
All ICUI newsICU Medical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IRTCiRhythm Holdings Inc. | 113.85 | +3.88% | $3.75B | vs ICUI |
| NVSTEnvista Holdings Corporation | 22.97 | +1.59% | $3.69B | vs ICUI |
| PLSEPulse Biosciences Inc | 50.84 | +6.92% | $3.63B | vs ICUI |
| HTFLHeartflow Inc. | 55.59 | +8.96% | $4.83B | vs ICUI |
| MMEDMiniMed Group Inc. | 17.49 | -1.69% | $4.92B | vs ICUI |
| ATRCAtriCure Inc. | 57.67 | +3.85% | $2.93B | vs ICUI |
| STVNStevanato Group S.p.A. | 19.01 | -0.05% | $5.19B | vs ICUI |
| HAEHaemonetics Corporation | 118.21 | -0.44% | $5.38B | vs ICUI |
Indexes, lists and sector
ICU Medical stock FAQ
What is ICU Medical's stock price today?
ICUI last traded at $161.08 as of Oct 20, 4:00 PM EDT, down 0.10% on the day. Prices are delayed at least 15 minutes.
Does ICU Medical pay a dividend?
No. ICU Medical does not currently pay a regular cash dividend.
When is ICU Medical's next earnings date?
ICU Medical is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $1.75.
What is ICUI's P/E ratio?
ICUI trades at a trailing P/E ratio of 135.36 and a forward P/E of 16.70, compared with a median of 48.4 for its closest peers.
Who is ICU Medical's CEO?
Mr. Vivek Jain is the chief executive officer of ICU Medical Inc., which has about 13,000 employees.
Has ICUI ever split its stock?
Yes. The most recent ICUI stock split was a 3-for-2 split on Mar 18, 2002, one of 2 splits on record.
What is the ICUI 52-week high?
The 52-week high for ICUI is $192.85 and the 52-week low is $113.37. The stock is currently 16.5% below its high.